logo-loader

Amazon.com unit abandons plan to sell pharmaceutical products, CNBC says

Last updated: 19:34 16 Apr 2018 BST, First published: 14:34 16 Apr 2018 BST

Amazon.com box
Amazon Business failed to convince hospitals to change the way they purchase products

Amazon.com Inc.'s (NASDAQ:AMZN) Business unit, which sells bulk items to companies, has abandoned a plan to sell pharmaceutical products after weighing it last year, according to a report by CNBC, citing people familiar with the matter.

Amazon Business’s decision is partly because it failed to persuade hospitals to change the way they purchase products and cut out middlemen from the deals, CNBC said.

Another issue was that Amazon Business would have had to build an extensive logistics network that could accomodate drugs and other pharmaceutical products, which are sensitive to temperature, according to the report.

The retreat from the pharmaceutical space was seen as favorable by investors in pharmacies. CVS Health Corp. gained 5.7% to US$67.00 in early afternoon trading, while the Walgreens Boots Alliance Inc., which owns Walgreens and Boots, jumped 4.1% to US$66.43.

Amazon Business may consider getting into pharmaceuticals again as it gains size, according to CNBC.

Shares of Amazon.com were up 0.64% at US$1,439.50.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 39 minutes ago